Product Information
FENOFIBRIC ACID DR 45 MG CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1611 per EA under NDC 59651021690. Its NADAC has been published 337 times since Apr 22, 2020.
FDA first approved this application on Jul 25, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
45 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651021690
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FENOFIBRIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA212598FDA Approved
7/25/2019
TE Code
AB
On Market Since
7/25/2019
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRIC ACID DR 45 MG CAP has been published 337 times since Apr 22, 2020, and over the history we have for it it has declined 70.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1611 per EA |
|---|---|
| All-time high | $0.6533 (Aug 12, 2020) |
| All-time low | $0.1018 (Nov 20, 2024) |
| 52-week high | $0.1611 |
| 52-week low | $0.1423 |
| Median price | $0.1885 |
| Average price | $0.2506 |
| Largest weekly change | +100.8% (Dec 22, 2021) |
| Weeks tracked | 337 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FENOFIBRIC ACID market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRIC ACID DR 45 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRIC ACID DR 45 MG CAP, manufactured by Aurobindo Pharma Limited, is $0.1611 per EA (NDC 59651021690), effective Sep 30, 2026.
How has the price of FENOFIBRIC ACID DR 45 MG CAP changed over time?
Over the history we have for it, the NADAC for FENOFIBRIC ACID DR 45 MG CAP has declined 70.3%. It has been tracked across 337 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for FENOFIBRIC ACID DR 45 MG CAP?
Since Apr 22, 2020, the NADAC for FENOFIBRIC ACID DR 45 MG CAP has ranged from a low of $0.1018 (Nov 20, 2024) to a high of $0.6533 (Aug 12, 2020), with a median of $0.1885 per EA.
Are there cheaper alternatives to FENOFIBRIC ACID DR 45 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRIC ACID DR 45 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRIC ACID DR 45 MG CAP?
FENOFIBRIC ACID DR 45 MG CAP (NDC 59651021690) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.